Similar articles

• IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma.

  Mygland A, Tysnes OB, Aarli JA, Matre R, Gilhus NE. Mygland A, et al. J Autoimmun. 1993 Aug;6(4):507-15. doi: 10.1006/jaut.1993.1042. J Autoimmun. 1993. PMID: 8216692
• Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.

  Kawanami S, Tsuji R, Oda K. Kawanami S, et al. Ann Neurol. 1984 Feb;15(2):195-200. doi: 10.1002/ana.410150214. Ann Neurol. 1984. PMID: 6367620
• A simplified ELISA for anti-receptor antibodies in myasthenia gravis.

  Jailkhani BL, Asthana D, Jaffery NF, Kumar R, Ahuja GK. Jailkhani BL, et al. J Immunol Methods. 1986 Jan 22;86(1):115-8. doi: 10.1016/0022-1759(86)90273-5. J Immunol Methods. 1986. PMID: 3944465
• Myasthenia gravis studied by monoclonal antibodies to the acetylcholine receptor.

  Tzartos SJ. Tzartos SJ. In Vivo. 1988 Jan-Feb;2(1):105-10. In Vivo. 1988. PMID: 2979808 Review.
• Autoimmune diseases involving nicotinic receptors.

  Lindstrom J. Lindstrom J. J Neurobiol. 2002 Dec;53(4):656-65. doi: 10.1002/neu.10106. J Neurobiol. 2002. PMID: 12436428 Review.